Nitrilase mutant, construction method therefor, and application thereof

Patent metadata

Field	Value
Publication number	US-11492606-B2
Application number	US-201916968808-A
Country	US
Kind code	B2
Filing date	Jan 31, 2019
Priority date	Feb 9, 2018
Publication date	Nov 8, 2022
Grant date	Nov 8, 2022

Abstract

The present invention discloses a nitrilase mutant and its construction method and its application in the synthesis of chiral intermediate of pregabalin in the technical field of bioengineering. The present invention, respectively, takes turnip nitrilase BrNIT and arabidopsis nitrilase AtNIT as parent, using peptide fragment displacement method, displaces the sites 226-286 of BrNIT amino acid sequence and sites 225-285 of AtNIT amino acid sequence with sites 225-285 of Arabis alpina L. nitrilase AaNIT, obtain nitrilase mutants BrNIT225-285 and AtNIT225-285 of which the amino acid sequence is as shown in SEQ ID NO.1 or SEQ ID NO.3. Compared with wild type nitrilase, the activity of the nitrilase mutant provided by the present invention in catalyzing and hydrolyzing racemic IBSN and the stereoselectivity of the product show substantial improvement, it can satisfy the requirements of industrial application, and has good application prospect in efficient catalysis of racemic IBSN to synthesize 3-cyano-5-methylhexanoic Acid.

First claim

The invention claimed is:

1. A nitrilase mutant having the amino acid sequence of SEQ ID NO.1 or SEQ ID NO.3.

2. A coding gene for coding the nitrilase mutant according to claim 1 , wherein the coding gene has the nucleotide sequence of SEQ ID NO.2 or SEQ ID NO.4.

3. A recombinant vector containing the coding gene according to claim 2 .

4. A recombinant genetic engineering strain containing the recombinant vector according to claim 3 .

5. A method for preparing the nitrilase mutant of claim 1 , which is characterized in comprising the following steps:
(1) based on turnip nitrilase gene or arabidopsis nitrilase gene sequence, designing a PCR primer by using Arabis alpina L, cDNA as a template, utilizing the primer to amplify to obtain a DNA fragment I or a DNA fragment II that contains nucleotide positions 673-855 of the Arabis alpina L, nitrilase nucleotide sequence (SEQ ID NO: 8);
(2) taking a recombinant plasmid that carries turnip nitrilase gene or arabidopsis nitrilase gene sequence as a template, utilizing reverse PCR amplification to obtain a Brassica rapa nitrilase (BrNIT) plasmid fragment lack in nucleotide positions 676-858 of the turnip nitrilase nucleotide sequence (SEQ ID NO: 6) or obtain the Arabidopsis thaliana nitrilase (AtNIT) plasmid fragment lack in nucleotide positions 673-855 of the arabidopsis nitrilase nucleotide sequence (SEQ ID NO: 10);
(3) recombining the DNA fragment I with the BrNIT plasmid fragment or recombining the DNA fragment II with the AtNIT plasmid fragment, and introducing the recombinant product into the host bacteria, filtering to obtain nitrilase mutant expression strain;
(4) conducting induced expression to the nitrilase mutant expression strain to obtain the nitrilase mutant.

6. A method of using the nitrilase mutant of claim 1 in catalyzing racemic isobutylsuccinonitrile (IBSN) to prepare (S)-3-cyano-5-methylhexanoic acid, the method comprising the steps of:
taking wet cells comprising a polynucleotide encoding the nitrilase mutant of claim 1 , immobilized cells of the wet cells or pure enzyme extracted from ultrasonication of the wet cells as a catalyst,
using racemic IBSN as a substrate, and
using buffer solution of pH 5.0-10.0 as a reaction medium to conduct hydrolysis reaction at 25-45° C. and 100-300 rpm;
after complete reaction, obtaining a mixture containing (S)-3-cyano-5-methylhexanoic acid, separating and purifying the mixture to obtain (S)-3-c5-methylhexanoic acid.

7. The method according to claim 6 , which is characterized in that, in the reaction system, the final concentration of the substrate is 0.5-1.5 M, use amount of the catalyst is calculated based on weight of the wet cell at 10-30 g/L.

8. The method according to claim 6 , which is characterized in that, reaction medium is Tris-HCl buffer solution with pH 8.0.

9. The method according to claim 6 , which is characterized in that, the wet cells are recombinant E. coli BL21(DE3)/pET28b-BrNIT 225-285 or E. coli BL21(DE3)/pET28b-AtNIT 225-285 containing nitrilase mutant coding gene; and wherein the method of fermental culture comprises: inoculating recombinant E. coli containing nitrilase mutant coding gene in a LB culture medium containing kanamycin and culturing until OD 600 =0.6-0.8, adding isopropyl-β-D-thiogalactopyranoside of final concentration 0.1 mM, conducting induced culture at 28° C. for 10-12 hours, conducting centrifugation, collecting cells and obtaining the wet cell; wherein BrNIT represents Brassica rapa nitrilase and AtNIT represents Arabidopsis thaliana nitrilase.

Assignees

• Univ Zhejiang Technology

Inventors

• Zheng Renchao
• Zheng Yuguo
• Zhang Qin
• Wu Zheming
• Tang Xiaoling
• Lu Xiafeng

Classifications

• C12N15/70

  Vectors or expression systems specially adapted for E. coli · CPC title

• C12Y305/05001

  Nitrilase (3.5.5.1) · CPC title

• C12P13/002

  Nitriles (-CN) · CPC title

• C12P13/00

  Preparation of nitrogen-containing organic compounds · CPC title

• C12N9/78 Primary

  acting on carbon to nitrogen bonds other than peptide bonds (3.5) · CPC title